These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

570 related items for PubMed ID: 17342752

  • 1. Non-invasive bioluminescent detection of prostate cancer growth and metastasis in a bigenic transgenic mouse model.
    Hsieh CL, Xie Z, Yu J, Martin WD, Datta MW, Wu GJ, Chung LW.
    Prostate; 2007 May 15; 67(7):685-91. PubMed ID: 17342752
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model.
    Foster BA, Gingrich JR, Kwon ED, Madias C, Greenberg NM.
    Cancer Res; 1997 Aug 15; 57(16):3325-30. PubMed ID: 9269988
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Androgen-independent prostate cancer progression in the TRAMP model.
    Gingrich JR, Barrios RJ, Kattan MW, Nahm HS, Finegold MJ, Greenberg NM.
    Cancer Res; 1997 Nov 01; 57(21):4687-91. PubMed ID: 9354422
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
    Haram KM, Peltier HJ, Lu B, Bhasin M, Otu HH, Choy B, Regan M, Libermann TA, Latham GJ, Sanda MG, Arredouani MS.
    Prostate; 2008 Oct 01; 68(14):1517-30. PubMed ID: 18668517
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Metastatic prostate cancer in a transgenic mouse.
    Gingrich JR, Barrios RJ, Morton RA, Boyce BF, DeMayo FJ, Finegold MJ, Angelopoulou R, Rosen JM, Greenberg NM.
    Cancer Res; 1996 Sep 15; 56(18):4096-102. PubMed ID: 8797572
    [Abstract] [Full Text] [Related]

  • 12. Disruption of arginase II alters prostate tumor formation in TRAMP mice.
    Mumenthaler SM, Rozengurt N, Livesay JC, Sabaghian A, Cederbaum SD, Grody WW.
    Prostate; 2008 Oct 01; 68(14):1561-9. PubMed ID: 18663728
    [Abstract] [Full Text] [Related]

  • 13. Genistein alters growth factor signaling in transgenic prostate model (TRAMP).
    Wang J, Eltoum IE, Lamartiniere CA.
    Mol Cell Endocrinol; 2004 Apr 30; 219(1-2):171-80. PubMed ID: 15149738
    [Abstract] [Full Text] [Related]

  • 14. Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer.
    Polnaszek N, Kwabi-Addo B, Peterson LE, Ozen M, Greenberg NM, Ortega S, Basilico C, Ittmann M.
    Cancer Res; 2003 Sep 15; 63(18):5754-60. PubMed ID: 14522896
    [Abstract] [Full Text] [Related]

  • 15. A null-mutation in the Znt7 gene accelerates prostate tumor formation in a transgenic adenocarcinoma mouse prostate model.
    Tepaamorndech S, Huang L, Kirschke CP.
    Cancer Lett; 2011 Sep 01; 308(1):33-42. PubMed ID: 21621325
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Visualization of advanced human prostate cancer lesions in living mice by a targeted gene transfer vector and optical imaging.
    Adams JY, Johnson M, Sato M, Berger F, Gambhir SS, Carey M, Iruela-Arispe ML, Wu L.
    Nat Med; 2002 Aug 01; 8(8):891-7. PubMed ID: 12134144
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.